EUVIMEDEUVIMED entdecken
Crossref

Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer

Mario de Angelis iD, Carolin Siech iD, Francesco Di Bello iD, Natali Rodriguez Peñaranda iD, Jordan A Goyal iD, Zhe Tian, Nicola Longo, Felix K H Chun, Stefano Puliatti iD, Fred Saad iD, Shahrokh F Shariat, Giorgio Gandaglia und 5 weitere

BJU International · 2025

DOI: 10.1111/bju.16571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJU International, 2025. Verfasst von Mario de Angelis und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, QC, Canada. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cystectomy, Prostatic Neoplasms, Neoplasms, Radiation-Induced. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To conduct a population‐based study examining cancer‐specific mortality (CSM) and other‐cause mortality (OCM) differences in patients with radiation‐induced secondary bladder cancer (RT‐BCa) vs those with primary bladder cancer (pBCa) undergoing radical cystectomy (RC).

Methods

Within the Surveillance, Epidemiology, and End Results database (2004–2020), we identified patients with T 2–4 N 0–3 M 0 bladder cancer treated with RC, who had previously been treated with external beam radiation therapy (EBRT) or brachytherapy for prostate cancer, as well as patients with T 2–4 N 0–3 M 0 pBCa treated with RC. Cumulative incidence plots and multivariable competing risks regression (CRR) models were used to assess CSM after additional adjustment for OCM. The same methodology was then repeated based on organ‐confined (OC: T 2 N 0 M 0 ) and non‐organ‐confined (NOC: T 3–4 and/or N 1–3 ) disease.

Results

Of 9957 RC patients, RT‐BCa was identified in 347 (3%) compared with 9610 (97%) who had pBCa. In multivariable CRR models, no CSM differences were recorded in the overall comparison ( P = 0.8), nor in sub‐groups based on OC and NOC disease ( P = 0.8 and 0.7, respectively). Conversely, multivariable CRR models identified RT‐BCa as an independent predictor of 1.3‐fold higher OCM in the overall cohort and of 1.5‐fold higher OCM in those with NOC disease. In a sensitivity analysis of patients with NOC disease, EBRT was associated with higher OCM rates (hazard ratio 1.5). By contrast, OCM rates were not different in those with OC disease ( P = 0.8).

Conclusion

Our study showed that RC for RT‐BCa was associated with similar CSM rates as RC for pBCa, regardless of disease stage. However, patients who had undergone EBRT exhibited significantly higher OCM in the NOC sub‐group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCystectomyProstatic NeoplasmsNeoplasms, Radiation-InducedNeoplasms, Second PrimaryHumansMaleAgedMiddle AgedSEER ProgramRetrospective StudiesUnited States

Stichwörter der Autor:innen

bladder cancercancer‐specific mortalityother‐cause mortalityradical cystectomyradiotherapy

Autor:innen und Institutionen

  • Division of Urology, Cancer Prognostics and Health Outcomes Unit, University of Montréal Health Center, Montréal, QC, Canada.
  • Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Vita-Salute San Raffaele University, Milan, Italy.
  • Frankfurt, Goethe University Frankfurt am Main, Frankfurt am Main, Germany.
  • Department of Neurosciences, Science of Reproduction and Odontostomatology, University of Naples Federico II, Naples, Italy.
  • Department of Urology, AOU di Modena, University of Modena and Reggio Emilia, Modena, Italy.

ORCID-Profile: Mario de Angelis, Carolin Siech, Francesco Di Bello, Natali Rodriguez Peñaranda, Jordan A Goyal, Stefano Puliatti, Fred Saad, Francesco Montorsi

Zitieren

APA

de Angelis, M., Siech, C., Di Bello, F., Rodriguez Peñaranda, N., Goyal, J. A., Tian, Z., Longo, N., Chun, F. K. H., Puliatti, S., Saad, F., Shariat, S. F., Gandaglia, G., Moschini, M., Longoni, M., Montorsi, F., Briganti, A., & Karakiewicz, P. I. (2025). Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer. BJU International. https://doi.org/10.1111/bju.16571

Vancouver

de Angelis M, Siech C, Di Bello F, Rodriguez Peñaranda N, Goyal JA, Tian Z, et al. Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer. BJU International. 2025. doi:10.1111/bju.16571

BibTeX
@article{deAngelis2025,
  author = {de Angelis, Mario and Siech, Carolin and Di Bello, Francesco and Rodriguez Peñaranda, Natali and Goyal, Jordan A and Tian, Zhe and Longo, Nicola and Chun, Felix K H and Puliatti, Stefano and Saad, Fred and Shariat, Shahrokh F and Gandaglia, Giorgio and Moschini, Marco and Longoni, Mattia and Montorsi, Francesco and Briganti, Alberto and Karakiewicz, Pierre I},
  title = {Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer},
  journal = {BJU International},
  year = {2025},
  doi = {10.1111/bju.16571}
}
Kostenlos starten →